On Wall Street, there’s a certain silence that speaks louder than the cacophony. Last winter, BlackRock, the world’s biggest asset manager, began discreetly buying Archer Aviation shares. That silence was deafening. Out of glass towers in Midtown Manhattan, the largest financial pile in the world determined that a small San Jose-based manufacturer of electric aircraft was worth about $366 million of its $14 trillion. It’s the kind of action that causes analysts to stop in the middle of their coffee.
Archer’s journey hasn’t been simple. The company has spent years battling the gap between vision and execution, going public on a wave of hype in 2021, missing production targets, and delivering just one test aircraft thus far. Its Midnight eVTOL appears promising on paper and impressive in flight footage. It is intended to transport four passengers approximately 100 miles at 150 miles per hour. However, order books are not the same as deliveries, even if there is a $6 billion “indicative” backlog of 1,200 aircraft. That is evident to anyone who has watched the stock chart over the previous 12 months.
What makes BlackRock interested, then? It’s possible that the company recognizes what most individual investors fail to see: that the eVTOL market is one of those infrequent technological opportunities where being ahead of the curve is more important than making money. A $366 million position is, to be honest, a rounding error because BlackRock uses such large numbers. However, unless someone in the building has done the math on regulation, manufacturing partners, and the FAA’s slow march, the company rarely makes such large investments in speculative aerospace ventures.
As this develops, it seems more like BlackRock is positioning than betting. Early in 2026, the stake increased from 6.9% to 8.1%, and the buying pattern—deliberate and incremental—looks more like building a long position than a quick trade. Archer’s manufacturing partner, Stellantis, has scaled up production at its Covington, Georgia facility more slowly than anticipated. That is a serious issue. However, this is also the type of issue for which patient capital is designed.
The curiosity is explained by the customer list. These planes are desired by United Airlines. Ethiopian Airlines, the U.S. Air Force, and a Japanese joint venture between Japan Airlines and Sumitomo all do the same. The use cases—such as military reconnaissance, air taxi services to airports, and the replacement of helicopters for quick urban hops—grow more quickly than the certifications.
The skepticism is reasonable, though. With an estimated $32 million in revenue this year, Archer has a market capitalization of about $4.2 billion. A value investor would recoil at the sales multiple that results from that. The business isn’t making money. It won’t happen for some time. Commercial flights have not yet received full FAA clearance, and each quarter that passes raises concerns about dilution and cash burn.
Here, it’s difficult to ignore the parallel. Ten years ago, Tesla faced nearly the same doubts: losing money, missing deadlines, and being ridiculed by Detroit. It turned out that some of those doubters were correct about the timeline but incorrect about the destination. Archer’s story might be comparable. It could also serve as a warning about what happens when capital pursues a future that either doesn’t materialize at all or arrives later than anticipated.
It appears that BlackRock is purchasing a tiny, regulated exposure to that uncertainty. Not quite conviction. optionality. And that’s frequently sufficient for a company handling $14 trillion.